|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
AIOM AIRTUM, SIAPEC-IAP: I Cancer numbers
in Italy, Intermedia editore, September 2020.
|
|
3
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Thun M, Linet MS, Cerhan JR, Haiman CA and
Schottenfeld D: Cancer Epidemiology and Prevention. 4th edition.
Oxford University Press, pp925-946, 2018.
|
|
5
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36
Cancers in 185 Countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Loopik DL, IntHout J, Ebisch RMF, Melchers
WJG, Massuger LFAG, Siebers AG and Bekkers RLM: The risk of
cervical cancer after cervical intraepithelial neoplasia grade 3: A
population-based cohort study with 80,442 women. Gynecol Oncol.
157:195–201. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Global HPV Vaccine Introduction Overview:
Projected and current national introductions, demonstration/pilot
projects, gender-neutral vaccination programs, and global HPV
vaccine introduction maps (2006-2023). PATH, 2020. Available from:
path.org/resources/global-hpv-vaccine-introduction-overview/.
|
|
8
|
World Health Organization (WHO): ‘Best
buys’ and other recommended interventions for the prevention and
control of non-communicable diseases: Updated Appendix 3 of the
Global Action Plan for the Prevention and Control of Non
communicable Diseases 2013-2020WHO, 2017. Available from:
who.int/ncds/governance/appendix3-update/en/).
Accessed on April 2024.
|
|
9
|
World Health Organization (WHO): WHO
guidelines for the use of thermal ablation for cervical pre-cancer
lesions. WHO, 2019. Available from: Who.int/reproductivehealth/publications/thermal-ablation-for-cervical-pre-cancer-lesions/en/).
Accessed on April 2024.
|
|
10
|
World Health Organization (WHO): WHO
Director-General calls for all countries to take action to help end
the suffering caused by cervical cancer. WHO, 2018. Available from:
who.int/reproductivehealth/call-to-action-elimination-cervical-cancer/en/).
Accessed on April 2024.
|
|
11
|
Mangone L, Borciani E, Michiara M,
Vicentini M, Carrozzi G, Mancuso P, Sacchettini C and Rossi P:
Tumors in the provinces of the Vast Northern Emilia Area: Piacenza,
Parma, Reggio Emilia and Modena: Years 2013-2014. The Cancer
Registries, 2015. https://www.ausl.mo.it/media/interno.pdf?x14278.
Accessed on April, 2024.
|
|
12
|
Fritz A, Percy C, Jack A, Shanmugaratnam
K, Sobin L, Parkin DM and Whelan S: International Classification of
Disease for Oncology. 3rd edition. World Health Organization,
2013.
|
|
13
|
Sobin L, Gospodarowicz M and Wittekind C:
TNM Classification of Malignant Tumours. 7th edition. UICC,
Wiley-Blackwell, Hoboken, NJ, 2010.
|
|
14
|
ECIS (European Cancer Information System).
https://ecis.jrc.ec.europa.eu/ (accessed
on April 2024).
|
|
15
|
Yang M, Du J, Lu H, Xiang F, Mei H and
Xiao H: Global trends and age-specific incidence and mortality of
cervical cancer from 1990 to 2019: An international comparative
study based on the global burden of disease. BMJ Open.
12(e055470)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yuan M, Zhao X, Wang H, Hu S and Zhao F:
Trend in cervical cancer incidence and mortality rates in China,
2006-2030: A bayesian age-period-cohort modeling study. Cancer
Epidemiol Biomarkers Prev. 32:825–833. 2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sun K, Zheng R, Lei L, Zhang S, Zeng H,
Wang S, Li L, Chen R, Han B, Peng J, et al: Trends in incidence
rates, mortality rates, and age-period-cohort effects of cervical
cancer-China, 2003-2017. China CDC Wkly. 4:1070–1076.
2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Raveinthiranathan N, Simkin J, Donken R,
Ogilvie G, Smith L, Van Niekerk D, Lee M and Woods RR: Age-specific
trends of invasive cervical cancer incidence in British Columbia,
Canada, 1971-2017. Curr Oncol. 30:7692–7705. 2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kau YC, Liu FC, Kuo CF, Huang HJ, Li AH,
Hsieh MY and Yu HP: Trend and survival outcome in Taiwan cervical
cancer patients: A population-based study. Medicine (Baltimore).
98(e14848)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rossi PG, Marsili LM, Camilloni L, Iossa
A, Lattanzi A, Sani C, Di Pierro C, Grazzini G, Angeloni C,
Capparucci P, et al: The effect of self-sampled HPV testing on
participation to cervical cancer screening in Italy: A randomised
controlled trial (ISRCTN96071600). Br J Cancer. 104:248–254.
2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bogani G, DI Donato V, Sopracordevole F,
Ciavattini A, Ghelardi A, Lopez S, Simoncini T, Plotti F, Casarin
J, Serati M, et al: Recurrence rate after loop electrosurgical
excision procedure (LEEP) and laser Conization: A 5-year follow-up
study. Gynecol Oncol. 159:636–641. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Giannini A, Di Donato V, Sopracordevole F,
Ciavattini A, Ghelardi A, Vizza E, D'Oria O, Simoncini T, Plotti F,
Casarin J, et al: Outcomes of high-grade cervical dysplasia with
positive margins and HPV persistence after cervical conization.
Vaccines (Basel). 11(698)2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bogani G, Sopracordevole F, Di Donato V,
Ciavattini A, Ghelardi A, Lopez S, Simoncini T, Plotti F, Casarin
J, Serati M, et al: High-risk HPV-positive and -negative high-grade
cervical dysplasia: Analysis of 5-year outcomes. Gynecol Oncol.
161:173–178. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ochs K, Meili G, Diebold J, Arndt V and
Günthert A: Incidence trends of cervical cancer and its
precancerous lesions in women of Central Switzerland from 2000
until 2014. Front Med (Lausanne). 5(58)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sivaranjini K, Oak A, Cheulkar S,
Maheshwari A, Mahantshetty U and Dikshit R: Role of education and
income on disparities of time-to-treatment initiation and its
impact on cervical cancer survival. Indian J Public Health.
67:235–239. 2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gnade CM, Hill EK, Botkin HE, Hefel AR,
Hansen HE, Sheets KA, Mott SL, Hardy-Fairbanks AJ and Stockdale CK:
Is the age of cervical cancer diagnosis changing over time? J
Gynecol Obstet Hum Reprod. 50(102040)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Cooley JJP, Maguire FB, Morris CR,
Parikh-Patel A, Abrahão R, Chen HA and Keegan THM: Cervical cancer
stage at diagnosis and survival among women ≥65 years in
california. Cancer Epidemiol Biomarkers Prev. 32:91–97.
2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hull R, Mbele M, Makhafola T, Hicks C,
Wang SM, Reis RM, Mehrotra R, Mkhize-Kwitshana Z, Kibiki G, Bates
DO and Dlamini Z: Cervical cancer in low and middle-income
countries. Oncol Lett. 20:2058–2074. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Baasland I, Vie GÅ, Romundstad PR and
Lönnberg S: Cervical cancer mortality in Norway according to
screening attendance and age. Acta Obstet Gynecol Scand.
101:952–959. 2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kassa R, Irene Y, Woldetsadik E, Kidane E,
Higgins M, Dejene T and Wells J: Survival of women with cervical
cancer in East Africa: A systematic review and meta-analysis. J
Obstet Gynaecol. 43(2253308)2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mwaliko E, Itsura P, Keter A, De Bacquer
D, Buziba N, Bastiaens H, Jackie A, Obala A, Naanyu V, Gichangi P
and Temmerman M: Survival of cervical cancer patients at Moi
teaching and referral hospital, Eldoret in Western Kenya. BMC
Cancer. 23(1104)2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Quinn BA, Deng X, Colton A, Bandyopadhyay
D, Carter JS and Fields EC: Increasing age predicts poor cervical
cancer prognosis with subsequent effect on treatment and overall
survival. Brachytherapy. 18:29–37. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Benitez-Restrepo CC, Arias-Ortiz NE and
Arboleda-Ruiz WA: Cervical cancer incidence and patient survival in
Manizales, Colombia, 2008-2012. Rev Peru Med Exp Salud Publica.
37:438–445. 2020.PubMed/NCBI View Article : Google Scholar : (In Spanish,
English).
|
|
35
|
Bruni L, Serrano B, Roura E, Alemany L,
Cowan M, Herrero R, Poljak M, Murillo R, Broutet N, Riley LM and de
Sanjose S: Cervical cancer screening programmes and age-specific
coverage estimates for 202 countries and territories worldwide: A
review and synthetic analysis. Lancet Glob Health. 10:e1115–e1127.
2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Cohen CM, Wentzensen N, Castle PE,
Schiffman M, Zuna R, Arend RC and Clarke MA: Racial and ethnic
disparities in cervical cancer incidence, survival, and mortality
by histologic subtype. J Clin Oncol. 41:1059–1068. 2023.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Azerkan F, Zendehdel K, Tillgren P,
Faxelid E and Sparén P: Risk of cervical cancer among immigrants by
age at immigration and follow-up time in Sweden, from 1968 to 2004.
Int J Cancer. 123:2664–2670. 2008.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tjioe KC, Miranda-Galvis M, Johnson MS,
Agrawal G, Balas EA and Cortes JE: The interaction between social
determinants of health and cervical cancer survival: A systematic
review. Gynecol Oncol. 181:141–154. 2024.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Donkers H, Bekkers R and Galaal K:
Systematic review on socioeconomic deprivation and cervical cancer:
Inequalities in survival. J Health Care Poor Underserved.
32:751–766. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hung P, Zahnd WE, Brandt HM, Adams SA,
Wang S and Eberth JM: Cervical cancer treatment initiation and
survival: The role of residential proximity to cancer care. Gynecol
Oncol. 160:219–226. 2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liu G, Yang Z and Wang D: A Bayesian
network predicting survival of cervical cancer patients-Based on
surveillance, epidemiology, and end results. Cancer Sci.
114:1131–1141. 2023.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Wang C, Lester B, Huang L, Sun S and Ko
JJ: Patient, disease, and survival outcomes for stage IB to stage
IV cervical cancer-A population study. Womens Health (Lond).
19(17455057231164551)2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Presidente del Consiglio dei Ministri:
Decreto del Presidente del Consiglio dei Ministri, 3/3/2017,41
Identificazione dei sistemi di sorveglianza e dei registri di
mortalità, di tumori e di altre patologie. 17A03142, GU Serie
Generale n.109 del (12-05-2017). Available from: https://www.gazzettaufficiale.it/eli/id/2017/05/12/17A03142/sg.
Accessed on May, 2024.
|
|
44
|
Cox DR: Regression models and life-tables.
Journal of the Royal Statistical Society, Series B. 34:187–220.
1972.
|
